This measures the effectiveness of compounds, known as secretagogues, in stimulating the pituitary gland to release endogenous Growth Hormone (GH). Efficacy is determined by the magnitude and duration of the resulting pulsatile GH release profile, which is vital for maintaining somatotropic function, particularly in aging cohorts. High efficacy translates to improved metabolic and body composition benefits.
Origin
The term unites “Growth Hormone,” the anabolic pituitary polypeptide, with “secretagogue,” meaning something that promotes secretion, and “efficacy,” which is the capacity to produce a desired result. Its clinical relevance stems from addressing age-related decline in somatopause, where GH output naturally diminishes. This concept focuses on optimizing the body’s internal GH regulation system.
Mechanism
Secretagogues function by mimicking or amplifying the signals that normally trigger GH release from the anterior pituitary, often involving modulation of ghrelin receptor activity or direct interaction with GHS-R1a receptors. Effective signaling overcomes the inhibitory tone exerted by somatostatin, allowing for a robust release of GH into the systemic circulation. This increased GH then acts on the liver to stimulate IGF-1 production, mediating systemic anabolic effects.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.